Harvard Bioscience Aktie: Diese News macht Mut!
Die Harvard Bioscience Aktie verzeichnete am letzten Handelstag eine positive Entwicklung mit einem Kursanstieg von 3,70 Prozent auf 2,24 USD.…
2,260$
0,89%
Echtzeit-Aktienkurs Harvard Bioscience
Bid:
Ask:
Nachrichten zur Harvard Bioscience Aktie
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
HOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…
Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript
…
Harvard Bioscience Announces Second Quarter 2024 Financial Results
HOLLISTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial…
Earnings call: Harvard Bioscience faces Q1 challenges, eyes H2 recovery By Investing.com
Earnings call: Harvard Bioscience faces Q1 challenges, eyes H2 recovery…
Harvard Bioscience, Inc. (HBIO) Q1 2024 Earnings Call Transcript
…
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force…
Harvard Bioscience shares get price target boost to $6.75 By Investing.com
Harvard Bioscience shares get price target boost to $6.75…
Earnings call: Harvard Bioscience reports steady performance amid challenges By Investing.com
Earnings call: Harvard Bioscience reports steady performance amid challenges…
Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript
…
Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation
…
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
HOLLISTON, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial…
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be…
Harvard Bioscience, Inc. (HBIO) Q3 2023 Earnings Call Transcript
…
Harvard Bioscience Announces Third Quarter 2023 Financial Results
HOLLISTON, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial…
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
Innovative solutions for academic, CRO, pharma and biotech customers Innovative solutions for academic, CRO, pharma and biotech customers…
Harvard Bioscience (HBIO) Q2 Earnings and Revenues Lag Estimates
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -20% and 2.51%, respectively, for the quarter ended June 2023. Do…
Harvard Bioscience Non-GAAP EPS of $0.04 misses by $0.02, revenue of $28.2M misses by $1.3M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Harvard Bioscience Announces Second Quarter 2023 Financial Results
HOLLISTON, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced…
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and…
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
HOLLISTON, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…
Harvard Bioscience to join Russell 2000 and Russell 3000 indexes
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes
HOLLISTON, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced that…
3 Instruments Stocks to Watch From a Prospering Industry
The Zacks Instruments - Scientific industry participants like Harvard Bioscience (HBIO), Mettler-Toledo (MTD) and Waters (WAT) are gaining from strong…
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
HOLLISTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and…
Why Harvard Bioscience Stock Rose This Week
The company reported improved revenue in Q1....…
Harvard Bioscience Non-GAAP EPS of $0.06 beats by $0.02, revenue of $29.98M beats by $1.53M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
Designed to meet the pre-clinical testing needs of CROs, pharma and research laboratories Designed to meet the pre-clinical testing needs…
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
HOLLISTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…
Insiderhandel: Aufsichtsrat kauft Aktien von Harvard Bioscience im Wert von 36.867$
Edrick, Alan I. - Aufsichtsrat - Tag der Transaktion: 2023-03-14...…
Insiderhandel: Aufsichtsrat kauft Aktien von Harvard Bioscience im Wert von 42.423$
Edrick, Alan I. - Aufsichtsrat - Tag der Transaktion: 2023-03-15...…
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and…
Insiderhandel: Chief Executive Officer kauft Aktien von Harvard Bioscience im Wert von 53.400$
Green, James W. - Vorstand - Tag der Transaktion: 2023-03-14...…
Insiderhandel: Chief Executive Officer kauft Aktien von Harvard Bioscience im Wert von 52.000$
Green, James W. - Vorstand - Tag der Transaktion: 2023-03-15...…
Form 8-K HARVARD BIOSCIENCE INC For: Mar 13
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-K HARVARD BIOSCIENCE INC For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Harvard Bioscience Non-GAAP EPS of $0.04 beats by $0.03, revenue of $28.4M misses by $1.75M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K HARVARD BIOSCIENCE INC For: Mar 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET
HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…
Form 8-K HARVARD BIOSCIENCE INC For: Jan 18
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K/A HARVARD BIOSCIENCE INC For: Dec 07
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Harvard Bioscience announces CFO transistion
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Harvard Bioscience CFO to Resign This Month
Harvard Bioscience CFO to Resign This Month...…
Harvard Bioscience Announces CFO Transition
HOLLISTON, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the…
Harvard Bioscience (HBIO) Reports Q3 Loss, Misses Revenue Estimates
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of -120% and 3.85%, respectively, for the quarter ended September 2022. Do…
Harvard Bioscience Non-GAAP EPS of -$0.01, revenue of $76.9M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K HARVARD BIOSCIENCE INC For: Nov 08
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET
HOLLISTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results…